NCT06218433View on ClinicalTrials.gov

Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2034

Conditions
Urothelial CarcinomaLynch Syndrome
Interventions
DIAGNOSTIC_TEST

Urothelial cancer screening using urine tumor DNA test

Urine sample DNA is analyzed using a targeted sequencing panel encompassing the coding regions of 21 genes that are recurrently mutated in urothelial cancer

DIAGNOSTIC_TEST

Urothelial cancer screening using urine cytology (comparator)

Urine cytology sample

Trial Locations (2)

Unknown

RECRUITING

Vancouver Prostate Centre, Vancouver

RECRUITING

Tampere University Hospital and Tampere University, Tampere

All Listed Sponsors
collaborator

Tampere University

OTHER

lead

Tampere University Hospital

OTHER